CA2347336A1 - A1 adenosine receptor agonists - Google Patents
A1 adenosine receptor agonistsInfo
- Publication number
- CA2347336A1 CA2347336A1 CA002347336A CA2347336A CA2347336A1 CA 2347336 A1 CA2347336 A1 CA 2347336A1 CA 002347336 A CA002347336 A CA 002347336A CA 2347336 A CA2347336 A CA 2347336A CA 2347336 A1 CA2347336 A1 CA 2347336A1
- Authority
- CA
- Canada
- Prior art keywords
- receptor agonists
- adenosine receptor
- formula
- adenosine
- see formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 101150007969 ADORA1 gene Proteins 0.000 title abstract 2
- 239000003379 purinergic P1 receptor agonist Substances 0.000 title abstract 2
- OIRDTQYFTABQOQ-KQYNXXCUSA-N Adenosine Natural products C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 abstract 1
- 239000002126 C01EB10 - Adenosine Substances 0.000 abstract 1
- 229960005305 adenosine Drugs 0.000 abstract 1
- -1 adenosine compound Chemical class 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 239000003416 antiarrhythmic agent Substances 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
An N6 adenosine compound of the formula:
(See Formula I) wherein R = (See Formula II or III) and R1 an alkyl group having 1-4 carbon atoms. Compounds according to the invention are A1 adenosine receptor agonists and may therefore be used as .beta.-blockers and antiarrhythmic agents.
(See Formula I) wherein R = (See Formula II or III) and R1 an alkyl group having 1-4 carbon atoms. Compounds according to the invention are A1 adenosine receptor agonists and may therefore be used as .beta.-blockers and antiarrhythmic agents.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/144,459 US5446046A (en) | 1993-10-28 | 1993-10-28 | A1 adenosine receptor agonists and antagonists as diuretics |
US144,459 | 1993-10-28 | ||
CA002172726A CA2172726C (en) | 1993-10-28 | 1994-10-28 | A1 adenosine receptor antagonists |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002172726A Division CA2172726C (en) | 1993-10-28 | 1994-10-28 | A1 adenosine receptor antagonists |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2347336A1 true CA2347336A1 (en) | 1995-05-04 |
CA2347336C CA2347336C (en) | 2004-08-24 |
Family
ID=25678393
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002347336A Expired - Fee Related CA2347336C (en) | 1993-10-28 | 1994-10-28 | A1 adenosine receptor agonists |
Country Status (1)
Country | Link |
---|---|
CA (1) | CA2347336C (en) |
-
1994
- 1994-10-28 CA CA002347336A patent/CA2347336C/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CA2347336C (en) | 2004-08-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2103861A1 (en) | Novel 7-(substituted)-8-(substituted-9-(substituted amino)-6-demethyl-6-deoxytetracyclines | |
CA2502856A1 (en) | Intermediates for retroviral protease inhibiting compounds | |
CA2103845A1 (en) | 9-[(substituted glycyl)-amido]-6-demethyl-6-deoxytetracyclines | |
WO1995007918A3 (en) | Pyrimidine derivatives for labeled binding partners | |
CA2159988A1 (en) | Novel deoxygalactonojirimycin derivatives | |
CA2120374A1 (en) | 9-[(substituted glycyl) amido]-6-(substituted)-5-hydroxy-6-deoxytetracyclines | |
CA2160137A1 (en) | Bicyclic Ansamycins | |
SG47559A1 (en) | 7-(substituted)-9-[(substituted glycl) amido]-6-demethyl-6-deoxytetracyclines | |
WO1999024450A3 (en) | Adensine a1 receptor agonists | |
AU4237793A (en) | Alkyl glycoside compositions with improved wetting properties | |
IL103301A0 (en) | Pyrimidine nucleoside derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same | |
UA70991C2 (en) | N2-phenylamidine derivatives, application thereof and intermediary compounds | |
CA2110693A1 (en) | Amino acid derivative anticonvulsant | |
WO1999024449A3 (en) | Adenosine a1 receptor agonists | |
NZ290721A (en) | Process for making quinolone-containing antimicrobial compounds | |
MY123083A (en) | Acyclic nucleoside derivatives | |
ES8705412A1 (en) | Furan derivatives having anti-ulcer activity. | |
CA2010035A1 (en) | Proline derivatives | |
CA2036228A1 (en) | Industrial antifungal composition | |
CA2347336A1 (en) | A1 adenosine receptor agonists | |
MY103393A (en) | 4-oxo-3-quinolinecarboxylic acids useful as antibacterial agents and preparation thereof | |
CA2146322A1 (en) | Oleaginous compositions | |
CA2025858A1 (en) | Antihepatopathic composition | |
ES8505684A1 (en) | 5-Substituted(1,2,4)triazolo(1,5-c)pyrimidin-2-amines. | |
GR3029590T3 (en) | Crystalline, polymorphic form of (s,s,s)-n-(1- 2-carboxy-3-(n?2 -mesyllysylamino)propyl]-1-cyclopentylcarbonyl)tyrosine |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
MKLA | Lapsed |
Effective date: 20131029 |